Dr. Allan M. Spiegel, MD

Dr. Spiegel practices at Allan M Spiegel MD PA in Palm Harbor, Florida.

Dr. Spiegel's NPI, 1235148743, was assigned on August 5, 2006. Dr. Spiegel graduated from University of the East College of Medicine in 1979. Dr. Spiegel holds Florida license ME45063.

Dr. Spiegel's primary practice is Allan M Spiegel MD PA, at 31608 Us-19 N, Palm Harbor, FL 34684 in Pinellas County. The practice phone is (727) 787-7077.

Dr. Spiegel's primary practice is Allan M Spiegel MD PA in Palm Harbor, Florida. Dr. Spiegel is also affiliated with Morton Plant Hospital. The medical group on file is Neurological Solutions. Dmand AI also links Dr. Spiegel to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Spiegel practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Spiegel's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Spiegel's licenses on file in 4 states: Florida, Pennsylvania, Tennessee and Georgia.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain and head injury among the conditions Dr. Spiegel treats.

CMS data shows 7,358 Medicare services from Dr. Spiegel across 30 procedure codes in 2024, for 751 Medicare patients. Medicare paid $594,583 for them. Every service was in an office.

CMS counts 751 Medicare patients who saw Dr. Spiegel in 2024. The largest group is 75 to 84, with 294 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Spiegel's median patient age at 71, with 58% women.

In 2024, Dr. Spiegel wrote 5,752 Medicare Part D claims for 1,097 patients. 88% of them were for generic drugs. CMS names the drug for 5,440 of them, across 81 drugs with 11 or more claims each, at $1,601,217 in total drug cost. In 2023, CMS named 5,022 claims across 87 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Spiegel for performance year 2024, reported individually. Dr. Spiegel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 12 procedures of removal of tissue by Dr. Spiegel, more than 63% of the clinicians it reports for that procedure.

Dmand AI links 127 papers to Dr. Spiegel in 2019. The most frequent topics are GTP-Binding Proteins, Hyperparathyroidism and Parathyroid Glands. Dr. Spiegel has published most often in Radiology. Dr. Spiegel's most frequent co-authors are Jeffrey A. Norton, MD, David G. Gardner, MD and John Jerome Merendino, MD.

CMS Open Payments shows 1,452 general payments to Dr. Spiegel from 68 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 76% of the total. Supernus Pharmaceuticals, Inc. paid the most, $11,280.

Dr. Spiegel graduated from University of the East College of Medicine in 1979. Dr. Spiegel is a member of Undersea and Hyperbaric Association.

Dr. Spiegel is in network with 5 carriers, including Aetna, Excellus BlueCross BlueShield and Cigna. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.